Biocytogen Pharmaceuticals Adjusts Fundraising Project, Extends Timeline

MT Newswires Live

09/17

Biocytogen Pharmaceuticals Beijing (SHA:688796, HKG:2315) raised the total investment for its drug early-stage research and development service platform construction project to 461.6 million yuan from 453.6 million yuan, according to a Thursday filing with the Shanghai bourse.

The internal investment structure will shift, cutting construction engineering payment by 254.1 million yuan while adding 135 million yuan for decoration, 119.1 million yuan for equipment, and 8 million yuan for site leasing.

The project completion date is extended to June 30, 2027, from Dec. 31, 2026.

Shares of the pharmaceutical company rose 6% in recent trade on the Hong Kong bourse.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2668789953"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2668789953\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2668789953?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-17 12:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2668789953","market":"sg","top_or_hot":-1,"title":"Biocytogen Pharmaceuticals Adjusts Fundraising Project, Extends Timeline","media":"MT Newswires Live","content":"<html><body><p> Biocytogen Pharmaceuticals Beijing (SHA:688796, HKG:2315) raised the total investment for its drug early-stage research and development service platform construction project to 461.6 million yuan from 453.6 million yuan, according to a Thursday filing with the Shanghai bourse.</p><p>The internal investment structure will shift, cutting construction engineering payment by 254.1 million yuan while adding 135 million yuan for decoration, 119.1 million yuan for equipment, and 8 million yuan for site leasing.</p><p>The project completion date is extended to June 30, 2027, from Dec. 31, 2026.</p><p>Shares of the pharmaceutical company rose 6% in recent trade on the Hong Kong bourse.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biocytogen Pharmaceuticals Adjusts Fundraising Project, Extends Timeline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiocytogen Pharmaceuticals Adjusts Fundraising Project, Extends Timeline\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-17 12:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Biocytogen Pharmaceuticals Beijing (SHA:688796, HKG:2315) raised the total investment for its drug early-stage research and development service platform construction project to 461.6 million yuan from 453.6 million yuan, according to a Thursday filing with the Shanghai bourse.</p><p>The internal investment structure will shift, cutting construction engineering payment by 254.1 million yuan while adding 135 million yuan for decoration, 119.1 million yuan for equipment, and 8 million yuan for site leasing.</p><p>The project completion date is extended to June 30, 2027, from Dec. 31, 2026.</p><p>Shares of the pharmaceutical company rose 6% in recent trade on the Hong Kong bourse.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02315","symbol_name":"百奥赛图-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2668789953","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2668789953","pubTimestamp":1789617652,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Biocytogen Pharmaceuticals Beijing  raised the total investment for its drug early-stage research and development service platform construction project to 461.6 million yuan from 453.6 million yuan, according to a Thursday filing with the Shanghai bourse.The internal investment structure will shift, cutting construction engineering payment by 254.1 million yuan while adding 135 million yuan for decoration, 119.1 million yuan for equipment, and 8 million yuan for site leasing.The project completion date is extended to June 30, 2027, from Dec. 31, 2026.Shares of the pharmaceutical company rose 6% in recent trade on the Hong Kong bourse.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688796":"百奥赛图","02315":"百奥赛图-B","BK0216":"研究试验","BK1161":"生物科技","FCA":"First Trust China AlphaDEX Fund"},"translate_title":"Biocytogen Pharmaceuticals 调整筹款项目并延长时间表","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688796":0.9,"FCA":0.9,"02315":0.9},"content_text":"Biocytogen Pharmaceuticals Beijing (SHA:688796, HKG:2315) raised the total investment for its drug early-stage research and development service platform construction project to 461.6 million yuan from 453.6 million yuan, according to a Thursday filing with the Shanghai bourse.The internal investment structure will shift, cutting construction engineering payment by 254.1 million yuan while adding 135 million yuan for decoration, 119.1 million yuan for equipment, and 8 million yuan for site leasing.The project completion date is extended to June 30, 2027, from Dec. 31, 2026.Shares of the pharmaceutical company rose 6% in recent trade on the Hong Kong bourse.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}